In OS, where endothelial activation and vascular patterning influence leukocyte entry and spatial organization, NGF-driven angiogenic signaling provides a credible mechanism for lymphocyte exclusion and myeloid-biased trafficking at tumor–bone interfaces. Here, NGF is linked to neoplasm.